Chemours Co Net Income (Loss) Attributable to Parent in USD from 2013 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Chemours Co quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2013 to Q3 2025.
  • Chemours Co Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2025 was $60M.
  • Chemours Co Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2025 was -$333M, a 620% decline year-over-year.
  • Chemours Co annual Net Income (Loss) Attributable to Parent for 2024 was $70M.
  • Chemours Co annual Net Income (Loss) Attributable to Parent for 2023 was -$238M, a 141% decline from 2022.
  • Chemours Co annual Net Income (Loss) Attributable to Parent for 2022 was $578M, a 4.93% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)

Chemours Co Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$333M $60M +$92M Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-06
Q2 2025 -$425M -$381M -$441M -735% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-05
Q1 2025 $16M -$4M -$58M -107% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-06
Q4 2024 $74M -$8M +$10M +55.6% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-18
Q3 2024 $64M -$32M -$44M -367% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-06
Q2 2024 $108M $60M +$436M Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-05
Q1 2024 -$328M $54M -$91M -62.8% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-06
Q4 2023 -$237M -$18M +$79M +81.4% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-18
Q3 2023 -$316M $12M -$228M -95% Jul 1, 2023 Sep 30, 2023 10-K 2025-02-18
Q2 2023 -$88M -$376M -$577M -287% Apr 1, 2023 Jun 30, 2023 10-K 2025-02-18
Q1 2023 $489M $145M -$89M -38% Jan 1, 2023 Mar 31, 2023 10-K 2025-02-18
Q4 2022 $578M -$97M -$329M -142% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-27
Q3 2022 $907M $240M +$26M +12.2% Jul 1, 2022 Sep 30, 2022 10-K 2024-03-27
Q2 2022 $881M $201M +$135M +205% Apr 1, 2022 Jun 30, 2022 10-K 2024-03-27
Q1 2022 $746M $234M +$138M +144% Jan 1, 2022 Mar 31, 2022 10-K 2024-03-27
Q4 2021 $608M $232M +$213M +1121% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-27
Q3 2021 $395M $214M +$138M +182% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-26
Q2 2021 $257M $66M +$42M +175% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-01
Q1 2021 $215M $96M -$4M -4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 $219M $19M +$336M Oct 1, 2020 Dec 31, 2020 10-K 2023-02-10
Q3 2020 -$117M $76M $0 0% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 -$117M $24M -$72M -75% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-30
Q1 2020 -$45M $100M +$6M +6.38% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 -$51M -$317M -$459M -323% Oct 1, 2019 Dec 31, 2019 10-K 2020-02-14
Q3 2019 $408M $76M -$199M -72.4% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 $607M $96M -$185M -65.8% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-31
Q1 2019 $792M $94M -$203M -68.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 $995M $142M -$86M -37.7% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-14
Q3 2018 $1.08B $275M +$68M +32.9% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-14
Q2 2018 $1.01B $281M +$120M +74.5% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-14
Q1 2018 $893M $297M +$147M +98% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-14
Q4 2017 $746M $228M +$458M Oct 1, 2017 Dec 31, 2017 10-K 2019-02-15
Q3 2017 $288M $207M +$3M +1.47% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-15
Q2 2017 $285M $161M +$179M Apr 1, 2017 Jun 30, 2017 10-K 2019-02-15
Q1 2017 $106M $150M +$99M +194% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-15
Q4 2016 $7M -$230M -$144M -167% Oct 1, 2016 Dec 31, 2016 10-K 2018-02-16
Q3 2016 $151M $204M +$233M Jul 1, 2016 Sep 30, 2016 10-K 2018-02-16
Q2 2016 -$82M -$18M $0 0% Apr 1, 2016 Jun 30, 2016 10-K 2018-02-16
Q1 2016 -$82M $51M +$8M +18.6% Jan 1, 2016 Mar 31, 2016 10-K 2018-02-16
Q4 2015 -$90M -$86M -$165M -209% Oct 1, 2015 Dec 31, 2015 10-K 2017-02-17
Q3 2015 $75M -$29M -$136M -127% Jul 1, 2015 Sep 30, 2015 10-K 2017-02-17
Q2 2015 $211M -$18M -$134M -116% Apr 1, 2015 Jun 30, 2015 10-K 2017-02-17
Q1 2015 $345M $43M -$55M -56.1% Jan 1, 2015 Mar 31, 2015 10-K 2017-02-17
Q4 2014 $400M $79M Oct 1, 2014 Dec 31, 2014 10-K 2016-02-25
Q3 2014 $107M Jul 1, 2014 Sep 30, 2014 10-K 2016-02-25
Q2 2014 $116M Apr 1, 2014 Jun 30, 2014 10-K 2016-02-25
Q1 2014 $98M Jan 1, 2014 Mar 31, 2014 10-K 2016-02-25

Chemours Co Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $70M +$308M Jan 1, 2024 Dec 31, 2024 10-Q 2025-05-06
2023 -$238M -$816M -141% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-18
2022 $578M -$30M -4.93% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-18
2021 $608M +$389M +178% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-27
2020 $219M +$271M Jan 1, 2020 Dec 31, 2020 10-K 2023-02-10
2019 -$52M -$1.05B -105% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-11
2018 $995M +$249M +33.4% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-12
2017 $746M +$739M +10557% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-14
2016 $7M +$97M Jan 1, 2016 Dec 31, 2016 10-K 2019-02-15
2015 -$90M -$490M -123% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-16
2014 $400M -$23M -5.44% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-17
2013 $423M Jan 1, 2013 Dec 31, 2013 10-K 2016-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.